Your Article Summary
See Latest ArticlesPRO: hydroxyethylstarch can be safely used in the intensive care patient--the renal debate
Intensive Care Medicine, 06/19/09
Boldt J - Hyperoncotic HES should not be used in patients who are at risk of developing kidney dysfunction. In patients without preexisting kidney dysfunction there seems to be no negative effects of modern HES preparations. In septic patients with reduced kidney function HES should be used cautiously, because studies of these patients are not available. Dissolving HES in a balanced solution further improves the safety of HES with regard to kidney function. At present, there seems to be no good reason to generally ban use of HES in the patients.
Related Articles
The Science of Stewardship: Due Diligence for Kidney Donors and Kidney Function in Living Kidney Donation—Evaluation, Determinants, and Implications for Outcomes
Clinical Journal of the American Society of Nephrology, 10/08/09
Relevance Score: 71%
Kidney Disease Missed in Women
Ivanhoe, 11/04/09
Relevance Score: 70%
Rapid Decline of Kidney Function Increases Cardiovascular Risk in the Elderly
Journal of the American Society of Nephrology, 11/09/09
Relevance Score: 69%
Cause of Death in Multiorgan Donors and Its Relation to the Function of Transplanted Kidneys
Transplantation Proceedings, 11/10/09
Relevance Score: 68%
Understanding Diabetes Mellitus And Kidney Disease
Nephrology Nursing Journal, 10/02/09
Relevance Score: 68%
Today in Urogenital/Nephrology...keeping you current
Receive free subspecialty "5-minute updates" via email
Swarming hornet attacks: shock and acute kidney injury—a large case series from Vietnam
Nephrology Dialysis Transplantation, 12/03/09
The characteristics of acute kidney injury complicated in acute hepatitis A
Scandinavian Journal of Infectious Diseases, 12/01/09
Urinary liver-type fatty acid-binding protein predicts adverse outcomes in acute kidney injury
Kidney International, 11/30/09